FAM109B Activators
FAM109B Activators encompasses a range of compounds that indirectly influence the cellular milieu of the FAM109B protein, also known as PHETA2. These activators are not directly engaged in binding or altering the protein's structure but rather modulate the signaling pathways that PHETA2 is a part of or responds to. The activators include Wortmannin and LY294002, which by curtailing PI3K activity, can affect the phosphoinositide-dependent signaling cascades. These cascades are critical for numerous cellular processes, including those that govern endocytic trafficking, a process in which PHETA2 is actively involved.
Moreover, this chemical class also comprises of U0126 and PD98059, which selectively inhibit MEK1 and MEK2. The MAPK/ERK pathway is integral to the regulation of cellular proliferation, differentiation, and survival. Inhibition of this pathway can result in widespread effects on cellular signaling networks, which may alter the functional context within which PHETA2 operates. By affecting these upstream regulatory kinases These changes can have a consequential influence on the protein's role in endocytic trafficking.rgeting it.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of phosphoinositide 3-kinases (PI3Ks), which are involved in a multitude of cellular processes including those related to endocytosis and vesicle trafficking. By inhibiting PI3K, Wortmannin can influence cellular signaling and may indirectly affect the function of proteins involved in endocytic trafficking like PHETA2 | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a morpholine-containing chemical compound that acts as a broad-spectrum inhibitor of PI3K. Its role in inhibiting PI3Kα, PI3Kδ, and PI3Kβ as well as other kinases such as CK2 and DNA-PK suggests that it could alter signaling pathways, potentially having an impact on proteins related to these pathways, such as PHETA2 | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective and reversible inhibitor of MEK, which is part of the MAPK/ERK pathway. It prevents the activation of MEK1 and MEK2, thereby inhibiting the phosphorylation of MAP kinase substrates. This alteration in MEK activity could in turn affect downstream proteins that are linked to the MAPK/ERK signaling pathway, potentially including PHETA2 | ||||||